Send CathInfo's owner Matthew a gift from his Amazon wish list:
https://www.amazon.com/hz/wishlist/ls/25M2B8RERL1UO

Author Topic: Marijuana use sinful for Catholics?  (Read 77200 times)

0 Members and 1 Guest are viewing this topic.

Re: Marijuana use sinful for Catholics?
« Reply #35 on: December 31, 2021, 04:46:31 PM »

edit



Offline Meg

Re: Marijuana use sinful for Catholics?
« Reply #37 on: December 31, 2021, 04:47:41 PM »
MJ has been used medically in Europe since the Crusades. It was forbidden in the 20th century. All while the earth was a globe.

Where did they get the pot from, since the Crusades in Europe? Did the local hippies (or the equivalent thereof) grow it and sell it? Or was it imported from exotic locations? Did they also provide information that the earth was a globe, and not flat? I suppose that they could have had a movement to do both: sell pot and also try to prove that the earth is a globe. What would the name of such a group be, do you think?

Offline Mark 79

  • Supporter
Re: Marijuana use sinful for Catholics?
« Reply #38 on: December 31, 2021, 04:55:40 PM »
Can you point to a qualified and unbiased study which shows pot to be less toxic and more beneficial than alcohol?

Can you point to Church teaching which says that pot must be judged by the same moral theology as alcohol?

You (plural) point to the Church teaching about being "sober."  THAT is based on the risks of abuse.  I see no mention in 1 Thessalonians 5:7-9 of exceptions, so how exactly does the Church justify ANY use of alcohol? Return to first principles: avoid undue risk of self-harm (whether physically or spiritually).

Since you claim MJ use is different from alcohol use, the burden is on YOU to make the case for the moral or medical difference—on something more substantial than your half-baked [pun-intended] "opinion."

No. I cannot point to "a" single study, but to dozens, even hundreds of studies. Glad you asked. :jester:


Start here, my bibliography for a series of 8 articles I wrote about medical marijuana in 2010-2011 when it was an issue in our state:

Important reviews
University of California Center for Medical Cannabis Research—2010 Report to the Legislature
http://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdf
Review on clinical studies with cannabis and cannabinoids 2005-2009. Hazecamp A and Grotenhermen F. Cannabinoids 2010;5(special issue):1-21.
www.cannabis-med.org/data/pdf/en_2010_01_special.pdf
Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.
http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf
Emerging Clinical Applications for Cannabis and Cannabinoids: A Review of the Recent Scientific Literature, 2000 – 2010. Armentano P. NORML Foundation, Washington DC 2010.
http://norml.org/pdf_files/NORML_Clinical_Applications_for_Cannabis_and_Cannabinoids.pdf
Marijuana and Medicine: Assessing the Science Base. National Academy of Science Institute of Medicine, 1999
http://www.nap.edu/openbook.php?record_id=6376
popularized in: Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=R1
AIDS/HIV
University of California Center for Medical Cannabis Research—2010 Report to the Legislature
http://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdf
Human Immunodeficiency Virus (HIV)
http://www.norml.org/index.cfm?Group_ID=7485
“Marijuana and AIDS” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=86
ALS (Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease)
Amyotrophic Lateral Sclerosis (ALS)
http://www.norml.org/index.cfm?Group_ID=7004
Alzheimer's Disease
Alzheimer's Disease
http://norml.org/index.cfm?Group_ID=7003
Cachexia. Wasting syndrome
See sections 3.1 and 3.2 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.
http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf
Cancer
Gliomas/Cancer
http://www.norml.org/index.cfm?Group_ID=7008
“Marijuana and Cancer” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=95
Cannabis and Cannabinoids (PDQ®). National Cancer Institute. 2011.
http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional/page1
Cardiovascular disease
The Potential for Clinical Use of Cannabinoids in Treatment
of Cardiovascular Diseases. Durst R and Lotan C. Cardiovascular Therapeutics 2011 Feb;29(1):17-22. doi: 10.1111/j.1755-5922.2010.00233.x. Epub 2010 Oct 14.
http://www.ncbi.nlm.nih.gov/pubmed/20946323
The emerging role of the endocannabinoid system in cardiovascular disease. Pacher P, Steffens S. Semin Immunopathol. 2009 Jun;31(1):63-77. Epub 2009 Apr 9.
http://www.springerlink.com/content/a04103g160h16450/fulltext.pdf
Cannabinoid receptors in atherosclerosis. Steffens S, Mach F. Curr Opin Lipidol. 2006 Oct;17(5):519-26.
http://journals.lww.com/co-lipidology/Abstract/2006/10000/Cannabinoid_receptors_in_atherosclerosis.5.aspx
Cannabinoid receptors in acute and chronic complications of atherosclerosis. Mach F, Montecucco F, Steffens S. Br J Pharmacol. 2008 January; 153(2): 290–298.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/pdf/0707517a.pdf
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Pacher P, Haskó G. Br J Pharmacol. 2008 Jan;153(2):252-62. Epub 2007 Nov 19.
http://onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0707582/pdf
The role of the endocannabinoid system in atherosclerosis. Mach F, Steffens S. J Neuroendocrinol. 2008 May;20 Suppl 1:53-7.
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01685.x/pdf
Cardiovascular Effects of Cannabis | Medicinal Cannabis Information. Independent Drug Monitoring Unit, United Kingdom, undated
http://www.idmu.co.uk/canncardio.htm
Crohns Disease
Gastrointestinal Disorders
http://www.norml.org/index.cfm?Group_ID=7009
Endocannabinoid sysytem
The Endocannabinoid System as an Emerging Target of Pharmacotherapy. National Institute of Health: Pacher P, Bátkai S, Kunos G. Pharmacol Rev. 2006 Sep;58(3):389-462.
http://pharmrev.aspetjournals.org/content/58/3/389.full.pdf
Endocrine disease, diabetes
The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. Endocr Rev. 2006 Feb;27(1):73-100. Epub 2005 Nov 23.
http://fk.uwks.ac.id/elib/Arsip/Departemen/Biokimia/The%20Emerging%20Role%20of%20the%20Endocannabinoid%20System.pdf
Fibromyalgia
Nabilone for the Treatment of Pain in Fibromyalgia. Skrabek RQ, Galimova L, Ethans K, Perry D. J Pain. 2008 Feb;9(2):164-73. Epub 2007 Nov 5.
http://docs.google.com/viewer?a=v&q=cache:9gDyCVhqJSMJ:files.meetup.com/404848/2008_Nabilone-for-the-Treatment-of-Pain-in-Fibromyalgia.pdf+Nabilone+for+the+Treatment+of+Pain+in+Fibromyalgia&hl=en&gl=us&pid=bl&srcid=ADGEESjFGavzxEJkBjsOj_YyWPHuo5PRG034PLna8X6n3sXGT696PVuaEH15HF07xVpfV10wLPfon8-nZoD0RcJfU6LInnuqHOGpKDECN4oQ6OWBgGgwXWckH2QB31FTn1BZn0KX9U7A&sig=AHIEtbQlDN8uMzxJIm6KKL0POTJdhmbsvg
Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief. Schley M, Legler A, Skopp G, Schmelz M, Konrad C, Rukwied R. Curr Med Res Opin. 2006 Jul;22(7):1269-76.
http://www.ncbi.nlm.nih.gov/pubmed/16834825
Fibromyalgia
http://norml.org/index.cfm?Group_ID=7007
Glaucoma
American Glaucoma Society position statement: Marijuana and the treatment of glaucoma. American Glaucoma Society, Prepared by Henry Jampel, M.D., M.H.S., August 10, 2009
http://www.americanglaucomasociety.net/associations/5224/files/Marijuana%20and%20Glaucoma%20august%2030_BOD%20Approved%2010.23.09.pdf
Marijuana and Glaucoma” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=124
Hepatitis C
Hepatitis C
http://www.norml.org/index.cfm?Group_ID=7010
Marijuana effects, drug levels, DUI
Marijuana effect and delta9-tetrahydrocannabinol plasma level. Chiang CWN and Barnett G. Clinical Pharmacology and Therapeutics 1984 Aug;36(2):234-8.
http://www.ncbi.nlm.nih.gov/pubmed/6086207
Contact highs and urinary cannabinoids excretion after passive exposure to marijuana smoke. Cone EJ and Johnson RE. Clinical Pharmacology and Therapeutics 1986 Sep;40(3):247-56.
http://www.ncbi.nlm.nih.gov/pubmed/3017628
Do delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Pope HG, Herning R, Cadet JL, Huestis MA. Addiction. 2009 Dec;104(12):2041-8. Epub 2009 Oct 5.
http://www.clinchem.org/cgi/reprint/49/7/1114
Developing limits for driving under cannabis. Grotenhermen F, Leson G, Berghaus G, Drummer OH, Krüger HP, Longo M, Moskowitz H, Perrine B, Ramaekers JG, Smiley A, Tunbridge R. Addiction 2007 Dec;102(12):1910-7. Epub 2007 Oct 4.
http://www.ncbi.nlm.nih.gov/pubmed/17916224
Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans. Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Clin Chem. 2003 Jul;49(7):1114-24.
http://www.ncbi.nlm.nih.gov/pubmed/12816908
Editorial: Practical Challenges to Positive Drug Tests for Marijuana. ElSohly MA. Clin Chem. 2003 Jul;49(7):1037-8.
http://www.clinchem.org/cgi/reprint/49/7/1037
Dose related risk of motor vehicle crashes after cannabis use. Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Drug Alcohol Depend. 2004 Feb 7;73(2):109-19.
http://www.ukcia.org/research/DoseRelatedRiskOfCrashes.pdf
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G. Psychopharmacology (Berl). 2011 Mar;214(2):391-401. Epub 2010 Oct 30.
http://www.cannabistherapyinstitute.com/bills/dui/raemakers.etal.pdf
Cannabis and Driving: A Scientific and Rational Review. Armentano P. NORML Foundation, Washington DC 2010
http://norml.org/index.cfm?Group_ID=7459
Sex differences in the effects of marijuana on simulated driving performance. Anderson BM, Rizzo M, Block RI, Pearlson GD, O'Leary DS. J Psychoactive Drugs. 2010 Mar;42(1):19-30.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033009/
Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. Ronen A, Gershon P, Drobiner H, Rabinovich A, Bar-Hamburger R, Mechoulam R, Cassuto Y, Shinar D. Accid Anal Prev. 2008 May;40(3):926-34. Epub 2007 Nov 26.
http://www.ncbi.nlm.nih.gov/pubmed/18460360
Muscle Spasms
Dystonia
http://www.norml.org/index.cfm?Group_ID=7006
“Marijuana and Muscle Spasticity” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=106
Nausea
See sections 3.1 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.
http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf
Pain
University of California Center for Medical Cannabis Research—2010 Report to the Legislature
http://www.cmcr.ucsd.edu/images/pdfs/CMCR_REPORT_FEB17.pdf
Chronic Pain
http://www.norml.org/index.cfm?Group_ID=7786
“Marijuana and Pain” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=77#
Post traumatic Stress Disorder
Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. Ganon-Elazar E, Akirav I. J Neurosci. 2009 Sep 9;29(36):11078-88.
http://www.jneurosci.org/content/29/36/11078.full.pdf+html
[Extinction of emotional response as a novel approach of pharmacotherapy of anxiety disorders]. Lehner M, Wisłowska-Stanek A, Płaznik A. Psychiatr Pol. 2009 Nov-Dec;43(6):639-53.
http://www.ncbi.nlm.nih.gov/pubmed/20209877
The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD). Fraser GA. CNS Neurosci Ther. 2009 Winter;15(1):84-8.
http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2008.00071.x/pdf
Public policy
Harm reduction-the cannabis paradox. Melamede R. Harm Reduct J. 2005 Sep 22;2:17.
http://www.harmreductionjournal.com/content/pdf/1477-7517-2-17.pdf
Seizures
See sections 3.7 of Cannabinoids in medicine: A review of their therapeutic potential. Amar MB. Journal of Ethnopharmacology 105 (2006) 1–25.
http://www.ucla.edu.ve/dmedicin/departamentos/fisiologia/cannabinoidsRevPatologias.pdf
“Marijuana and Neurological Disorders” in Marijuana As Medicine? – The Science Behind the Controversy. Mack A and Joy J. National Academy of Science. National Academy Press, Washington DC 2000.
http://books.nap.edu/openbook.php?record_id=9586&page=115


Offline Mark 79

  • Supporter
Re: Marijuana use sinful for Catholics?
« Reply #39 on: December 31, 2021, 04:56:10 PM »
Glad you asked. :laugh1::laugh2::jester::fryingpan::incense::facepalm: